Lindenwold Advisors INC Sells 2,445 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Lindenwold Advisors INC reduced its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 20.5% during the 4th quarter, HoldingsChannel reports. The fund owned 9,485 shares of the company’s stock after selling 2,445 shares during the period. Lindenwold Advisors INC’s holdings in Stevanato Group were worth $207,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in STVN. Conestoga Capital Advisors LLC raised its stake in shares of Stevanato Group by 5.3% in the fourth quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company’s stock valued at $176,128,000 after acquiring an additional 407,086 shares during the period. TimesSquare Capital Management LLC lifted its stake in Stevanato Group by 114.6% in the fourth quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company’s stock worth $71,657,000 after purchasing an additional 1,756,100 shares during the last quarter. Thrivent Financial for Lutherans boosted its position in shares of Stevanato Group by 67.6% during the third quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock valued at $55,698,000 after buying an additional 1,123,104 shares during the period. Wellington Management Group LLP grew its stake in shares of Stevanato Group by 4.5% during the third quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock valued at $53,872,000 after buying an additional 115,050 shares during the last quarter. Finally, Bamco Inc. NY raised its holdings in shares of Stevanato Group by 1.3% in the third quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock worth $33,704,000 after buying an additional 21,469 shares during the period.

Analysts Set New Price Targets

Several equities analysts have commented on the company. Bank of America upped their price objective on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, December 13th. UBS Group cut their price target on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a report on Friday, March 7th. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. William Blair restated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Finally, Wolfe Research started coverage on shares of Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Stevanato Group currently has a consensus rating of “Moderate Buy” and an average price target of €27.75 ($30.49).

Stevanato Group Price Performance

Shares of STVN opened at €21.92 ($24.09) on Wednesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The company has a 50 day moving average price of €21.12 and a 200-day moving average price of €20.58. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($18.20) and a fifty-two week high of €33.49 ($36.80). The stock has a market capitalization of $6.64 billion, a PE ratio of 46.64, a PEG ratio of 7.18 and a beta of 0.60.

Stevanato Group (NYSE:STVN) last posted its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company had revenue of €352.68 million during the quarter, compared to analyst estimates of €346.26 million. Equities analysts predict that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.